Cinven is arranging around €1.5 billion ($1.7 billion) in debt financing to support its acquisition of specialty pharmaceutical company Theramex, according to people familiar with the matter.
Goldman Sachs and Morgan Stanley, described as sellside advisers, are expected to take leading roles in the financing alongside Jefferies Financial Group, an adviser to Cinven, the people said. The package is likely to include leveraged loans and a revolving credit facility.
Sources: Bloomberg Markets.